Mo, Asipre and the MFO have sold close to 100M sha
Post# of 72440
As for a B-OM deal, I guess whoever questions why Leo hasn’t found a partner while Gelera found one in 2018 is a basher/short/criminal. Both trials concluded in late 2017. Leo claimed B-OM is superior than GC4419, which I agree because oral rinse is better than IV. Yooper61 who went to the shareholders meeting said the following.
Quote:
Asked, what are the prospects for a B-OM deal? Leo said he couldn’t say, then Dr. B spoke up and said, “I’m still here after 3 years, and if I didn’t believe, I wouldn’t be here anymore.”
That message was posted last September. I’m not here to argue whether Yooper’s report was credible. Assuming you believe him, what are your thoughts on Dr. B’s departure in relation to a B-OM deal? TIA!